Skip to main content
. 2022 Apr 21;3(5):100323. doi: 10.1016/j.jtocrr.2022.100323

Figure 1.

Figure 1

OncoPrint of genomic information using targeted NGS panel STAMP (n = 15), Foundation One (n = 2), and NCI-Match (n = 1). Pathogenic or likely pathogenic mutations are reported separately from VUS. AD, autoimmune disease; NCI, National Cancer Institute; NGS, next-generation sequencing; OS, overall survival; STAMP, Solid Tumor Actionable Mutation Panel; TC, thymic carcinoma; VUS, variant of unknown significance.